Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia 17Lymphoma 14Lymphoma, Large B-Cell, Diffuse 12Multiple Myeloma 10Lymphoma, Follicular 10Leukemia, Myeloid, Acute 10Breast Neoplasms 10Lymphoma, Non-Hodgkin 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Lymphoma, Mantle-Cell 6Leukemia, Myelomonocytic, Acute 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, Monocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Myeloproliferative Disorders 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Testicular Neoplasms 4Myelodysplastic Syndromes 4Congenital Abnormalities 4Waldenstrom Macroglobulinemia 3Testicular Germ Cell Tumor 3Teratoma, Testicular 3Teratoma 3Seminoma 3

Interventions

Lenalidomide 3daratumumab 2Dexamethasone 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Watchful Waiting 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Observation 1Melphalan 1Maintenance 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Smoldering Multiple Myeloma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00114101 2026-05-29

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

National Cancer Institute (NCI)

Phase 3 Active not recruiting
460 enrolled 11 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡